PAREXEL has launched the PAREXEL BioPharm Unit, a dedicated unit focused on the needs of small and mid-sized biopharma companies to help them achieve their development goals. The new delivery model was designed to provide a high level of attention and service with the goal of providing tailored solutions to accelerate development timelines and reduce costs, with a high level of quality.
 
The BioPharm Unit provides a senior management leader and dedicated team offering ongoing communication and solutions for patient recruitment, study start-up, shortened time to database lock, and improved efficiency for meeting development milestones.   
 
“Small and mid-sized biopharma companies are truly the genesis of innovation and have been an important part of PAREXEL's client base for more than 30 years,” said Ubavka DeNoble, vice president of BioPharm Services. “The creation of the PAREXEL BioPharm Unit is especially important for small pharma and biotech sponsors that have needs that are meaningfully different from large pharma sponsors. The breadth and depth of our expertise gives us the ability to create customized solutions that are designed to meet the particular needs of each client, whether the company is a small research venture, a growing mid-sized business, or a global enterprise.”